
The Risk of Trump’s Marijuana Order
The president’s move to loosen marijuana restrictions risks sending the wrong message about the drug.
Our health writers explore wellness culture, human behavior, mortality and disease, and other mysteries of the body and the mind.

The president’s move to loosen marijuana restrictions risks sending the wrong message about the drug.

Most cases are mild, obscuring the disease’s worst outcomes.

While NIH director Jay Bhattacharya focuses on podcasting, his second in command is dramatically remaking the agency.

A new lawsuit likens food companies to the tobacco industry. But it’s much harder to do something about junk food than about cigarettes.

Denial only serves the aims of anti-vaxxers.

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

RFK Jr.’s allies are in full control of U.S. immunization policy.

As Millennials enter their Rogaine era, the hair-loss industry is eager to receive them.

The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients.

We don’t need to do this every year.